Perguntar
Consultar
Descobrir
Calcular
Cadastre-se
Cadastre-se
Entrar
Entrar
Descobrir
HR+/HER2− early breast cancer: Adjuvant and neoadjuvant anthracycline-taxane strategies show similar survival - Notícias Vera Health